2024 |
Lloyd, M., Loke, P., Ashley, S., Lozinsky, A. C., Orsini, F., O'Sullivan, M., . . . Tang, M. L. (2024). Interaction between baseline participant factors and treatment effects following peanut oral immunotherapy. Journal of Allergy and Clinical Immunology: In Practice, 12(4), 1019-1028.e2. DOI |
2023 |
Tran, H. A., Deng, L., Wood, N., Choi, P., Singleton, S., Clarke, L., . . . Chen, V. M. (2023). The clinicopathological features of thrombosis with thrombocytopenia syndrome following ChAdOx1-S (AZD1222) vaccination and case outcomes in Australia: a population-based study. The Lancet Regional Health - Western Pacific, 40, 13 pages. DOI Scopus3 Europe PMC1 |
2023 |
Nyambayo, P. P. M., Gold, M. S., Mehta, U. C., Clarke, S., Manyevere, R., Chirinda, L., . . . Nyamandi, T. (2023). Efficacy and feasibility of SMS m-Health for the detection of adverse events following immunisation (AEFIs) in resource-limited setting-The Zimbabwe stimulated telephone assisted rapid safety surveillance (Zm-STARSS) randomised control trial. Vaccine, 41(45), 6700-6709. DOI |
2023 |
Gold, M. S., Amarasinghe, A., Greenhawt, M., Kelso, J. M., Kochhar, S., Yu-Hor Thong, B., . . . Law, B. (2023). Anaphylaxis: Revision of the Brighton collaboration case definition. Vaccine, 41(15), 2605-2614. DOI Scopus16 WoS7 Europe PMC6 |
2023 |
Hu, A., Lloyd, M., Loke, P., Chebar Lozinsky, A., O'Sullivan, M., Quinn, P., . . . Tang, M. L. (2023). Association of reaction symptoms and eliciting dose with health-related quality of life in children with peanut allergy. The journal of allergy and clinical immunology. In practice, 11(10), 3195-3202.e4. DOI |
2022 |
Netting, M. J., Gold, M. S., Quinn, P., Palmer, S., Makrides, M., & Green, T. J. (2022). Does SMS text messaging promote the early introduction of food allergens? a randomised controlled trial. Pediatric Allergy and Immunology, 33(2), e13720-1-e13720-4. DOI Scopus3 WoS1 Europe PMC3 |
2022 |
Collinson, A. C., Moore, L., Cheung, A., Gold, M. S., & Goh, D. W. (2022). Subcutaneous nodules following vaccination.. Journal of paediatrics and child health, 58(3), 388-391. DOI |
2022 |
Loke, P., Orsini, F., Lozinsky, A. C., Gold, M., O'Sullivan, M. D., Quinn, P., . . . Ponsonby, A. L. (2022). Probiotic peanut oral immunotherapy versus oral immunotherapy and placebo in children with peanut allergy in Australia (PPOIT-003): a multicentre, randomised, phase 2b trial. The Lancet Child and Adolescent Health, 6(3), 171-184. DOI Scopus49 WoS7 Europe PMC21 |
2022 |
Yap, N., Buttery, J., Crawford, N. W., Omer, S., Heininger, U., Alafaci, A., . . . Wood, N. (2022). The impact of Australian childhood vaccination mandates on immunization specialists and their interactions with families. Pediatric Infectious Disease Journal, 41(5), E188-E193. DOI Scopus1 |
2022 |
Sherrey, J., Biggs, S., Dorrian, J., Martin, J., Gold, M., Kennedy, D., & Lushington, K. (2022). Allergic disease, sleep problems and psychological distress in children recruited from the general community. Annals of Allergy, Asthma, and Immunology, 129(3), 366-372. DOI Scopus3 WoS1 Europe PMC1 |
2022 |
Gold, M. S., Quinn, P. J., Campbell, D. E., Peake, J., Smart, J., Robinson, M., . . . Heine, R. G. (2022). Effects of an Amino Acid-Based Formula Supplemented with Two Human Milk Oligosaccharides on Growth, Tolerability, Safety, and Gut Microbiome in Infants with Cow's Milk Protein Allergy. NUTRIENTS, 14(11), 1-19. DOI Scopus10 WoS5 Europe PMC8 |
2022 |
Palmer, D. J., Sullivan, T. R., Campbell, D. E., Nanan, R., Gold, M. S., Hsu, P. S., . . . Makrides, M. (2022). PrEggNut Study: protocol for a randomised controlled trial investigating the effect of a maternal diet rich in eggs and peanuts from <23 weeks' gestation during pregnancy to 4 months' lactation on infant IgE-mediated egg and peanut allergy outcomes. BMJ Open, 12(6), e056925-1-e056925-8. DOI Scopus7 WoS6 Europe PMC1 |
2022 |
Tunbridge, M., Perkins, G., Lee, M., Salehi, T., Ryoo, D., Kette, F., . . . Hissaria, P. (2022). COVID vaccination can be performed in patients with a history of allergic reactions to the vaccines or their components: experience from a specialist clinic in South Australia. Internal Medicine Journal, 52(11), 1884-1890. DOI |
2021 |
Lai, C. L., Campbell, D. E., Palmer, D. J., Makrides, M., Santner-Nanan, B., Gold, M., . . . Hsu, P. S. (2021). Longitudinal egg-specific regulatory T and B cell development: insights from primary prevention clinical trials examining the timing of egg introduction.. Allergy, 76(5), 1385-1397. DOI Scopus5 WoS5 Europe PMC3 |
2021 |
Gold, M. S., Lincoln, G., Bednarz, J., Braunack-Mayer, A., & Stocks, N. (2021). Consumer acceptability and validity of m-Health for the detection of adverse events following immunization - The Stimulated Telephone Assisted Rapid Safety Surveillance (STARSS) randomised control trial. Vaccine, 39(2), 237-246. DOI Scopus3 |
2021 |
Amponsah-Dacosta, E., Muloiwa, R., Wiysonge, C. S., Gold, M., Hussey, G., & Kagina, B. M. (2021). Developing vaccinology expertise for africa: Fifteen years and counting. Pan African Medical Journal, 38, 313. DOI Scopus1 Europe PMC1 |
2021 |
Des Roches, A., Graham, F., Begin, P., Paradis, L., & Gold, M. (2021). Evaluation of Adverse Reactions to Vaccines. Journal of Allergy and Clinical Immunology: In Practice, 9(10), 3584-3597. DOI Scopus7 WoS4 Europe PMC3 |
2020 |
Perez Chacon, G., Estcourt, M. J., Totterdell, J., Campbell, D. E., Perrett, K. P., Marsh, J. A., . . . Snelling, T. L. (2020). OPTIMUM study protocol: an adaptive randomised controlled trial of a mixed whole-cell/acellular pertussis vaccine schedule. BMJ Open, 10(12), e042838-1-e042838-11. DOI Scopus5 WoS5 Europe PMC4 |
2020 |
Gold, M. S., Lincoln, G., Cashman, P., Braunack-Mayer, A., & Stocks, N. (2020). Efficacy of m-Health for the detection of adverse events following immunization – the stimulated telephone assisted rapid safety surveillance (STARSS) randomised control trial. Vaccine, 39(2), 332-342. DOI Scopus3 WoS2 Europe PMC1 |
2020 |
Damiano, J. A., Deng, L., Li, W., Burgess, R., Schneider, A. L., Crawford, N. W., . . . Berkovic, S. F. (2020). SCN1A Variants in vaccine-related febrile seizures: a prospective study. Annals of Neurology, 87(2), 281-288. DOI Scopus12 Europe PMC9 |
2020 |
Jacoby, P., Glover, C., Damon, C., Fathima, P., Pillsbury, A., Durrheim, D., . . . Snelling, T. (2020). Timeliness of signal detection for adverse events following influenza vaccination in young children: a simulation case study. BMJ open, 10(2), e031851. DOI Scopus5 Europe PMC4 |
2020 |
Gold, M. S., MacDonald, N. E., McMurtry, C. M., Balakrishnan, M. R., Heininger, U., Menning, L., . . . Zuber, P. L. F. (2020). Immunization stress-related response – Redefining immunization anxiety-related reaction as an adverse event following immunization. Vaccine, 38(14), 3015-3020. DOI Scopus53 Europe PMC39 |
2020 |
Omari, T., Tobin, J. M., McCall, L., Savage, K., Ferris, L., Hammond, P., . . . Heine, R. G. (2020). Characterization of upper gastrointestinal motility in infants with persistent distress and non-IgE-mediated cow's milk protein allergy. Journal of Pediatric Gastroenterology and Nutrition, 70(4), 489-496. DOI Scopus16 Europe PMC6 |
2020 |
Marshall, H. S., Koehler, A. P., Wang, B., A'Houre, M., Gold, M., Quinn, H., . . . Macartney, K. (2020). Safety of meningococcal B vaccine (4CMenB) in adolescents in Australia. Vaccine, 38(37), 5914-5922. DOI Scopus13 WoS7 Europe PMC4 |
2020 |
Deng, L., Wood, N., Macartney, K., Gold, M., Crawford, N., Buttery, J., . . . Barton, B. (2020). Developmental outcomes following vaccine-proximate febrile seizures in children. Neurology, 95(3), e226-e238. DOI Scopus3 |
2020 |
Netting, M. J., Gold, M. S., & Palmer, D. J. (2020). Low allergen content of commercial baby foods. Journal of Paediatrics and Child Health, 56(10), 1613-1617. DOI Scopus7 WoS5 Europe PMC4 |
2020 |
Chebar Lozinsky, A., Loke, P., Orsini, F., O'Sullivan, M., L Prescott, S., Gold, M. S., . . . Lk Tang, M. (2020). Study protocol of a multicentre, randomised, controlled trial evaluating the effectiveness of probiotic and peanut oral immunotherapy (PPOIT) in inducing desensitisation or tolerance in children with peanut allergy compared with oral immunotherapy (OIT) alone and with placebo (the PPOIT-003 study). BMJ Open, 10(9), e035871-1-e035871-10. DOI Scopus6 WoS3 Europe PMC2 |
2019 |
Estcourt, M. J., Campbell, D. E., Gold, M. S., Richmond, P., Allen, K. J., Quinn, H. E., . . . Snelling, T. L. (2019). Whole-cell pertussis vaccination and decreased Risk of IgE-mediated food allergy: a nested case-control study. The Journal of Allergy and Clinical Immunology: In Practice, 8(6), 2004-2014. DOI Scopus15 WoS8 Europe PMC9 |
2019 |
Blyth, C. C., Macartney, K. K., McRae, J., Clark, J. E., Marshall, H. S., Buttery, J., . . . Influenza Complications Alert Network (FluCAN) Collaboration. (2019). Influenza epidemiology, vaccine coverage and vaccine effectiveness in children admitted to sentinel Australian hospitals in 2017: results from the PAEDS-FluCAN Collaboration. Clinical Infectious Diseases, 68(6), 940-948. DOI Scopus42 WoS44 Europe PMC21 |
2019 |
Duszynski, K. M., Pratt, N. L., Lynch, J. W., Berry, J. G., & Gold, M. S. (2019). Use of different combination diphtheria-tetanus-acellular pertussis vaccines does not increase risk of 30-day infant mortality. A population-based linkage cohort study using administrative data from the Australian Childhood Immunisation Register and the National Death Index. Vaccine, 37(2), 280-288. DOI Scopus2 WoS2 Europe PMC1 |
2019 |
Volpi, S., Cicalese, M. P., Tuijnenburg, P., Tool, A. T. J., Cuadrado, E., Abu-Halaweh, M., . . . Kuijpers, T. W. (2019). A combined immunodeficiency with severe infections, inflammation, and allergy caused by ARPC1B deficiency. Journal of Allergy and Clinical Immunology, 143(6), 2296-2299. DOI Scopus82 WoS63 Europe PMC49 |
2019 |
Deng, L., Gidding, H., Macartney, K., Crawford, N., Buttery, J., Gold, M., . . . Wood, N. (2019). Postvaccination Febrile Seizure Severity and Outcome. Pediatrics, 143(5), 11 pages. DOI Scopus19 Europe PMC5 |
2019 |
Duszynski, K. M., Pratt, N. L., Lynch, J. W., Braunack-Mayer, A., Taylor, L. K., Berry, J. G., . . . Gold, M. S. (2019). Process trumps potential public good: better vaccine safety through linked cross-jurisdictional immunisation data in Australia. Australian and New Zealand Journal of Public Health, 43(5), 496-503. DOI Scopus8 WoS4 Europe PMC2 |
2018 |
Best, K. P., Sullivan, T. R., Palmer, D. J., Gold, M., Martin, J., Kennedy, D., & Makrides, M. (2018). Prenatal omega-3 LCPUFA and symptoms of allergic disease and sensitization throughout early childhood - a longitudinal analysis of long-term follow-up of a randomized controlled trial. World Allergy Organization Journal, 11(1), 10-1-10-11. DOI Scopus35 WoS28 Europe PMC22 |
2018 |
Pillsbury, A., Glover, C., Jacoby, P., Quinn, H., Fathima, P., Cashman, P., . . . Macartney, K. (2018). Active surveillance of 2017 seasonal influenza vaccine safety: an observational cohort study of individuals aged 6 months and older in Australia. BMJ Open, 8(10), 1-11. DOI Scopus29 Europe PMC19 |
2018 |
Patterson, J., Kagina, B., Gold, M., Hussey, G., & Muloiwa, R. (2018). Comparison of adverse events following immunisation with acellular and whole-cell pertussis vaccines: a systematic review. Vaccine, 36(40), 6007-6016. DOI Scopus19 Europe PMC10 |
2018 |
Ameratunga, R., Gillis, D., Gold, M., Linneberg, A., Hawkes, D., Langguth, D., & Elwood, M. (2018). Reply to Crépeaux et al and Blasco. Journal of Allergy and Clinical Immunology: In Practice, 6(2), 708-710. DOI Scopus2 |
2018 |
Estcourt, M. J., Marsh, J. A., Campbell, D. E., Gold, M. S., Allen, K. J., Richmond, P., . . . Snelling, T. L. (2018). Protocol for Pertussis Immunisation and Food Allergy (PIFA): a case-control study of the association between pertussis vaccination in infancy and the risk of IgE-mediated food allergy among Australian children. BMJ Open, 8(1), e020232-1-e020232-8. DOI Scopus3 WoS2 Europe PMC2 |
2017 |
Macartney, K., Gidding, H., Trinh, L., Wang, H., Dey, A., Hull, B., . . . Wood, N. (2017). Evaluation of combination measles-mumps-rubella-varicella vaccine introduction in Australia. JAMA Pediatrics, 171(10), 992-998. DOI Scopus34 WoS34 Europe PMC17 |
2017 |
Ameratunga, R., Gillis, D., Gold, M., Linneberg, A., & Elwood, J. M. (2017). Evidence refuting the existence of autoimmune/autoinflammatory syndrome induced by adjuvants (ASIA). Journal of Allergy and Clinical Immunology: In Practice, 5(6), 1551-1555.e1. DOI Scopus54 WoS45 Europe PMC24 |
2017 |
Mehr, S., Frith, K., Barnes, E., Campbell, D., Allen, K., Barnes, E., . . . Zurynski, Y. (2017). Food protein–induced enterocolitis syndrome in Australia: A population-based study, 2012-2014. Journal of Allergy and Clinical Immunology, 140(5), 1323-1330. DOI Scopus125 Europe PMC44 |
2017 |
Cashman, P., Macartney, K., Khandaker, G., King, C., Gold, M., & Durrheima, D. (2017). Participant-centred active surveillance of adverse events following immunisation: A narrative review. International Health, 9(3), 164-176. DOI Scopus29 WoS23 Europe PMC18 |
2017 |
Netting, M., Gold, M., Quinn, P., El-Merhibi, A., Penttila, I., & Makrides, M. (2017). Randomised controlled trial of a baked egg intervention in young children allergic to raw egg but not baked egg. World Allergy Organization Journal, 10(1), 22-1-22-9. DOI Scopus20 WoS16 Europe PMC11 |
2017 |
Palmer, D., Sullivan, T., Gold, M., Prescott, S., & Makrides, M. (2017). Randomized controlled trial of early regular egg intake to prevent egg allergy. Journal of Allergy and Clinical Immunology, 139(5), 1600. DOI Scopus152 WoS123 Europe PMC63 |
2017 |
Patterson, J., Kagina, B. M., Gold, M., Hussey, G. D., & Muloiwa, R. (2017). Adverse events following primary and secondary immunisation with whole-cell pertussis: A systematic review protocol. BMJ Open, 7(1), e012945. DOI Scopus2 Europe PMC1 |
2017 |
Palmer, D., Sullivan, T., Gold, M., Prescott, S., & Makrides, M. (2017). Association between family characteristics and the effect of timing of regular egg introduction in infant egg allergy. JAMA Pediatrics, 171(5), 489-490. DOI Scopus3 WoS3 Europe PMC1 |
2016 |
Dreskin, S., Halsey, N., Kelso, J., Wood, R., Hummell, D., Edwards, K., . . . Rosenwasser, L. (2016). International Consensus (ICON): allergic reactions to vaccines. World Allergy Organization Journal, 9(1), 32. DOI Scopus135 WoS115 Europe PMC73 |
2016 |
Camfferman, D., Short, M., Kennedy, J., Gold, M., Kohler, M., & Lushington, K. (2016). Thermoregulation, scratch, itch and sleep deficits in children with eczema. Sleep Medicine, 25, 145-150. DOI Scopus15 WoS11 Europe PMC11 |
2016 |
Best, K. P., Sullivan, T., Palmer, D., Gold, M., Kennedy, D. J., Martin, J., & Makrides, M. (2016). Prenatal fish oil supplementation and allergy: 6-year follow-up of a randomized controlled trial. Pediatrics, 137(6), 1-9. DOI Scopus53 WoS45 Europe PMC32 |
2016 |
Crawford, N., Hodgson, K., Gold, M., Buttery, J., & Wood, N. (2016). Adverse events following HPV immunization in Australia: establishment of a clinical network. Human Vaccines and Immunotherapeutics, 12(10), 2662-2665. DOI Scopus15 Europe PMC5 |
2016 |
Holt, P., Snelling, T., White, O., Sly, P., DeKlerk, N., Carapetis, J., . . . Gold, M. (2016). Transiently increased IgE responses in infants and pre-schoolers receiving only acellular Diphtheria–Pertussis–Tetanus (DTaP) vaccines compared to those initially receiving at least one dose of cellular vaccine (DTwP) – Immunological curiosity or canary in the mine?. Vaccine, 34(35), 4257-4262. DOI Scopus10 WoS6 Europe PMC6 |
2016 |
Zurzolo, G., Koplin, J., Ponsonby, A., McWilliam, V., Dharmage, S., Heine, R., . . . Allen, K. (2016). Consensus of stakeholders on precautionary allergen labelling: a report from the Centre for Food and Allergy Research. Journal of Paediatrics and Child Health, 52(8), 797-801. DOI Scopus18 WoS17 Europe PMC5 |
2016 |
Norman, M., South, C., Quinn, P., Chan, D., Palmer, S., Netting, M., & Gold, M. (2016). Does providing written dietary advice improve the ingestion of non-allergic nuts in children with existing nut allergies? - A randomized controlled trial. Clinical and Experimental Allergy, 46(5), 741-748. DOI Scopus9 WoS9 Europe PMC4 |
2016 |
Boyle, R., Tang, M. -K., Chiang, W., Chua, M., Ismail, I., Nauta, A., . . . Warner, J. (2016). Prebiotic-supplemented partially hydrolysed cow's milk formula for the prevention of eczema in high-risk infants: a randomized controlled trial. Allergy, 71(5), 701-710. DOI Scopus76 Europe PMC44 |
2016 |
Best, K., Gold, M., Kennedy, D., Martin, J., & Makrides, M. (2016). Omega-3 long-chain PUFA intake during pregnancy and allergic disease outcomes in the offspring: a systematic review and meta-analysis of observational studies and randomized controlled trials. American Journal of Clinical Nutrition, 103(1), 128-143. DOI Scopus127 WoS96 Europe PMC73 |
2016 |
Gold, M. S., Balakrishnan, M. R., Amarasinghe, A., & MacDonald, N. E. (2016). An approach to death as an adverse event following immunization. Vaccine, 34(2), 212-217. DOI Scopus16 Europe PMC10 |
2016 |
Metcalfe, J., D'Vaz, N., Makrides, M., Gold, M., Quinn, P., West, C., . . . Palmer, D. (2016). Elevated IL-5 and IL-13 responses to egg proteins predate the introduction of egg in solid foods in infants with eczema. Clinical and Experimental Allergy, 46(2), 308-316. DOI Scopus21 WoS17 Europe PMC10 |
2015 |
Macartney, K., Gidding, H., Trinh, L., Wang, H., McRae, J., Crawford, N., . . . Wood, N. (2015). Febrile seizures following measles and varicella vaccines in young children in Australia. Vaccine, 33(11), 1412-1417. DOI Scopus25 WoS22 Europe PMC10 |
2015 |
Netting, M., Donato, A., Makrides, M., Gold, M., Quinn, P., & Penttila, I. (2015). Allergenicity of pasteurized whole raw Hen’s egg compared with fresh whole raw Hen’s egg. Pediatric Allergy and Immunology, 26(3), 234-238. DOI Scopus16 WoS15 Europe PMC8 |
2015 |
Pillsbury, A., Cashman, P., Leeb, A., Regan, A., Westphal, D., Snelling, T., . . . Prince, K. (2015). Real-time safety surveillance of seasonal influenza vaccines in children, Australia, 2015. Eurosurveillance, 20(43), 5 pages. DOI Europe PMC18 |
2014 |
Harvey, G., Gold, M., & Warren, L. (2014). Allergy testing in paediatric atopic dermatitis. Medicine Today, 15(5), 42-46. |
2014 |
Khandaker, G., Zurynski, Y., Ridley, G., Buttery, J., Marshall, H., Richmond, P., . . . Elliott, E. (2014). Clinical epidemiology and predictors of outcome in children hospitalised with influenza A(H1N1)pdm09 in 2009: a prospective national study. Influenza and Other Respiratory Viruses, 8(6), 636-645. DOI Scopus22 WoS14 Europe PMC15 |
2014 |
Wood, N., Blyth, C., Willis, G., Richmond, P., Gold, M., Buttery, J., . . . Macartney, K. (2014). The safety of seasonal influenza vaccines in Australian children in 2013. Medical Journal of Australia, 201(10), 596-600. DOI Scopus12 Europe PMC5 |
2014 |
Parrella, A., Gold, M., Braunack-Mayer, A., Baghurst, P., & Marshall, H. (2014). Consumer reporting of adverse events following immunization (AEFI): Identifying predictors of reporting an AEFI. Human Vaccines & Immunotherapeutics, 10(3), 747-754. DOI Scopus12 WoS12 Europe PMC10 |
2013 |
Palmer, D., Sullivan, T., Gold, M., Prescott, S., Heddle, R., Gibson, R., & Makrides, M. (2013). Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy, 68(11), 1370-1376. DOI Scopus75 WoS61 Europe PMC49 |
2013 |
Camfferman, D., Kennedy, J., Gold, M., Simpson, C., & Lushington, K. (2013). Sleep and neurocognitive functioning in children with eczema. International Journal of Psychophysiology, 89(2), 265-272. DOI Scopus56 WoS42 Europe PMC35 |
2013 |
Parrella, A., Braunack-Mayer, A., Gold, M., Marshall, H., & Baghurst, P. (2013). Healthcare providers' knowledge, experience and challenges of reporting adverse events following immunisation: a qualitative study. BMC Health Services Research, 13(313), 1-12. DOI Scopus36 WoS34 Europe PMC24 |
2013 |
Palmer, D., Metcalfe, J., Makrides, M., Gold, M., Quinn, P., West, C., . . . Prescott, S. (2013). Early regular egg exposure in infants with eczema: a randomized controlled trial. Journal of Allergy and Clinical Immunology, 132(2), 387-392. DOI Scopus267 WoS227 Europe PMC142 |
2013 |
Netting, M., Makrides, M., Gold, M., Quinn, P., & Penttila, I. (2013). Heated allergens and induction of tolerance in food allergic children. Nutrients, 5(6), 2028-2046. DOI Scopus11 WoS12 Europe PMC7 |
2013 |
Berry, J., Ryan, P., Duszynski, K., Braunack-Mayer, A., Carlson, J., Xafis, V., & Gold, M. (2013). Parent perspectives on consent for the linkage of data to evaluate vaccine safety: A randomised trial of opt-in and opt-out consent. Clinical Trials, 10(3), 483-494. DOI Scopus13 WoS12 Europe PMC8 |
2013 |
Marshall, H., McIntyre, P., Richmond, P., Buttery, J., Royle, J., Gold, M., . . . Booy, R. (2013). Changes in patterns of hospitalized children with varicella and of associated varicella genotypes after introduction of varicella vaccine in Australia. Pediatric Infectious Disease Journal, 32(5), 530-537. DOI Scopus35 WoS30 Europe PMC23 |
2013 |
Parrella, A., Gold, M., Marshall, H., Braunack-Mayer, A., & Baghurst, P. (2013). Parental perspectives of vaccine safety and experience of adverse events following immunisation. Vaccine, 31(16), 2067-2074. DOI Scopus36 WoS30 Europe PMC23 |
2013 |
Newland, K., Warren, L., & Gold, M. (2013). Food allergy testing in infantile eczema: a clinical approach and algorithm. Australasian Journal of Dermatology, 54(2), 79-84. DOI Scopus8 WoS7 Europe PMC3 |
2013 |
Zurynski, Y., McIntyre, P., Booy, R., Elliott, E., & PAEDS Investigators Group.. (2013). Paediatric active enhanced disease surveillance: a new surveillance system for Australia. Journal of Paediatrics and Child Health, 49(7), 588-594. DOI |
2013 |
Dodd, C., Romio, S., Black, S., Vellozzi, C., Andrews, N., Sturkenboom, M., . . . Liu, S. (2013). International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines. Vaccine, 31(40), 4448-4458. DOI Scopus87 WoS78 Europe PMC53 |
2012 |
Khandaker, G., Zurynski, Y., Buttery, J., Marshall, H., Richmond, P., Dale, R., . . . Booy, R. (2012). Neurologic complications of influenza A(H1N1)pdm09: surveillance in 6 pediatric hospitals. Neurology, 79(14), 1474-1481. DOI Scopus67 WoS57 Europe PMC47 |
2012 |
Khandaker, G., Rashid, H., Zurynski, Y., Richmond, P., Buttery, J., Marshall, H., . . . Booy, R. (2012). Nosocomial vs community-acquired pandemic influenza A (H1N1) 2009: a nested case-control study. Journal of Hospital Infection, 82(2), 94-100. DOI Scopus8 WoS8 Europe PMC5 |
2012 |
Gold, M. (2012). A clinical approach to the investigation of suspected vaccine anaphylaxis. Current Allergy & Clinical Immunology, 25(2), 68-70. Scopus4 WoS4 |
2012 |
Parrella, A., Gold, M., Marshall, H., Braunack-Mayer, A., Watson, M., & Baghurst, P. (2012). Parental views on vaccine safety and future vaccinations of children who experienced an adverse event following routine or seasonal influenza vaccination in 2010. Human Vaccines & Immunotherapeutics, 8(5), 662-667. DOI Scopus18 WoS14 Europe PMC10 |
2012 |
Berry, J., Ryan, P., Gold, M., Braunack-Mayer, A., & Duszynski, K. (2012). A randomised controlled trial to compare opt-in and opt-out parental consent for childhood vaccine safety surveillance using data linkage. Journal of Medical Ethics, 38(10), 619-625. DOI Scopus16 WoS16 Europe PMC13 |
2012 |
Mullins, R., & Gold, M. (2012). Influenza vaccination of the egg-allergic individual: 2012 update. Medical Journal of Australia, 196(11), 682. DOI Scopus1 |
2012 |
Berry, J., Gold, M., Ryan, P., Duszynski, K., & Braunack-Mayer, A. (2012). Public perspectives on consent for the linkage of data to evaluate vaccine safety. Vaccine, 30(28), 4167-4174. DOI Scopus11 WoS9 Europe PMC6 |
2012 |
Boog, B., Quach, A., Costabile, M., Smart, J., Quinn, P., Singh, H., . . . Ferrante, A. (2012). Identification and functional characterization of two novel mutations in the α-helical loop (residues 484-503) of CYBB/gp91phox resulting in the rare X91⁺ variant of chronic granulomatous disease. Human Mutation, 33(3), 471-475. DOI Scopus7 WoS6 Europe PMC5 |
2012 |
Palmer, D., Sullivan, T., Gold, M., Prescott, S., Heddle, R., Gibson, R., & Makrides, M. (2012). Effect of n-3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. British Medical Journal, 344(7845), E184-1-E184-11. DOI Scopus185 WoS144 Europe PMC103 |
2012 |
Empson, M., Tang, M., Pearce, L., Rozen, L., Gold, M., Katelaris, C., . . . Maher, D. (2012). Efficacy, safety and pharmacokinetics of a novel subcutaneous immunoglobulin, Evogam®, in primary immunodeficiency. Journal of Clinical Immunology, 32(5), 897-906. DOI Scopus6 WoS5 Europe PMC5 |
2011 |
Mullins, R. J., & Gold, M. S. (2011). Influenza vaccination of the egg-allergic individual. Medical Journal of Australia, 195(1), 52. DOI Scopus2 WoS2 Europe PMC1 |
2011 |
Xafis, V., Thomson, C., Braunack-Mayer, A., Duszynski, K., & Gold, M. (2011). Legal impediments to data linkage. Journal of Law and Medicine, 19(2), 300-315. Scopus3 Europe PMC2 |
2011 |
Clarke, M., Davidson, G., Gold, M., & Marshall, H. (2011). Direct and indirect impact on rotavirus positive and all-cause gastroenteritis hospitalisations in South Australian children following the introduction of rotavirus vaccination. Vaccine, 29(29-30), 4663-4667. DOI Scopus52 WoS49 Europe PMC29 |
2011 |
Quinn, P., Gold, M., Royle, J., Buttery, J., Richmond, P., McIntyre, P., . . . Marshall, H. (2011). Recurrence of extensive injection site reactions following DTPa or dTpa vaccine in children 4-6 years old. Vaccine, 29(25), 4230-4237. DOI Scopus17 WoS18 Europe PMC9 |
2011 |
Khandaker, G., Marshall, H., Peadon, E., Zurynski, Y., Burgner, D., Buttery, J., . . . Booy, R. (2011). Congenital and neonatal varicella: impact of the national varicella vaccination programme in Australia. Archives of Disease in Childhood, 96(5), 453-456. DOI Scopus46 WoS36 Europe PMC23 |
2011 |
Berry, J., Ryan, P., Braunack-Mayer, A., Duszynski, K., Xafis, V., & Gold, M. (2011). A randomised controlled trial to compare opt-in and opt-out parental consent for childhood vaccine safety surveillance using data linkage: study protocol. Trials, 12(1), 1-10. DOI Scopus11 WoS11 Europe PMC59 |
2010 |
Camfferman, D., Kennedy, J., Gold, M., Martin, A., Winwood, P., & Lushington, K. (2010). Eczema, sleep, and behavior in children. The Journal of Clinical Sleep Medicine, 6(6), 581-588. DOI Scopus67 WoS60 Europe PMC38 |
2010 |
Zanoni, G., Gottin, L., Boner, A., Piacentini, G., Peroni, D., & Gold, M. (2010). Case discussion of an immediate serious reaction to hexavalent vaccine mistaken for anaphylaxis. British Journal of Clinical Pharmacology, 70(6), 916-917. DOI Scopus5 Europe PMC1 |
2010 |
Gold, M., Buttery, J., & McIntyre, P. (2010). Human papillomavirus vaccine safety in Australia: experience to date and issues for surveillance. Sexual Health, 7(3), 320-324. DOI Scopus16 WoS14 Europe PMC12 |
2010 |
Gold, M., Gidudu, J., Erlewyn-Lajeunesse, M., & Law, B. (2010). Can the Brighton Collaboration case definitions be used to improve the quality of Adverse Event Following Immunization (AEFI) reporting? Anaphylaxis as a case study. Vaccine, 28(28), 4487-4498. DOI Scopus36 WoS31 Europe PMC21 |
2010 |
Gold, M., Dugdale, S., Woodman, R., & Mc Caul, K. (2010). Use of the Australian Childhood Immunisation Register for vaccine safety data linkage. Vaccine, 28(26), 4308-4311. DOI Scopus30 Europe PMC15 |
2010 |
Camfferman, D., Kennedy, J., Gold, M., Martin, A., & Lushington, K. (2010). Eczema and sleep and its relationship to daytime functioning in children. Sleep Medicine Reviews, 14(6), 359-369. DOI Scopus113 WoS98 Europe PMC66 |
2010 |
Gold, M. S., Effler, P., Kelly, H., Richmond, P. C., & Buttery, J. P. (2010). Febrile convulsions after 2010 seasonal trivalent influenza vaccine: Implications for vaccine safety surveillance in Australia. Medical Journal of Australia, 193(9), 492-493. DOI Scopus34 WoS34 Europe PMC15 |
2010 |
Mullins, R. J., Kemp, A., & Gold, M. (2010). Influenza vaccination of the egg-allergic individual. Medical Journal of Australia, 193(5), 254-255. DOI Scopus6 Europe PMC2 |
2010 |
Mahajan, D., Roomiani, I., Gold, M. S., Lawrence, G. L., McIntyre, P. B., & Menzies, R. I. (2010). Annual report: surveillance of adverse events following immunisation in Australia, 2009.. Communicable Diseases Intelligence Quarterly Report, 34(3), 259-276. Scopus29 Europe PMC11 |
2009 |
Menzies, R., Mahajan, D., Gold, M., Roomianai, I., McIntyre, P., & Lawrence, G. (2009). Annual report: surveillance of adverse events following immunisation in Australia, 2008. Communicable Diseases Intelligence Quarterly Report, 33(4), 365-381. Scopus16 Europe PMC6 |
2009 |
Brotherton, J., Kemp, A., Burgess, M., & Gold, M. (2009). HPV vaccination reactions [Letter]. Australian Family Physician, 38(5), 381. |
2009 |
de Benedictis, F. M., Franceschini, F., Hill, D., Naspitz, C., Simons, F. E. R., Wahn, U., . . . Vogel, M. (2009). The allergic sensitization in infants with atopic eczema from different countries. Allergy: European Journal of Allergy and Clinical Immunology, 64(2), 295-303. DOI Scopus96 Europe PMC54 |
2009 |
Brotherton, J., Kemp, A., Burgess, M., & Gold, M. (2009). HPV vaccination reactions. Australian Family Physician, 38(5), 281. |
2009 |
Black, S., Eskola, J., Siegrist, C., Halsey, N., MacDonald, N., Law, B., . . . Vellozi, C. (2009). Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines. Lancet, 374(9707), 2115-2122. DOI Scopus215 Europe PMC133 |
2009 |
Bonhoeffer, J., Bentsi-Enchill, A., Chen, R., Fisher, M., Gold, M., Hartman, K., . . . Wise, R. (2009). Guidelines for collection, analysis and presentation of vaccine safety data in surveillance systems. Vaccine, 27(16), 2289-2297. DOI Scopus31 WoS28 Europe PMC21 |
2009 |
Bonhoeffer, J., Bentsi-Enchill, A., Chen, R., Fisher, M., Gold, M., Hartman, K., . . . Wise, R. (2009). Guidelines for collection, analysis and presentation of vaccine safety data in pre- and post-licensure clinical studies. Vaccine, 27(16), 2282-2288. DOI Scopus48 WoS43 Europe PMC28 |
2008 |
Kang, L., Crawford, N., Tang, M., Buttery, J., Royle, J., Gold, M., . . . Choo, S. (2008). Hypersensitivity reactions to human papillomavirus vaccine in Australian schoolgirls: retrospective cohort study. British Medical Journal, 337(a2642), 1-5. DOI Scopus47 WoS37 Europe PMC22 |
2008 |
Brotherton, J., & Gold, M. (2008). Monitoring vaccine safety: a critical component of every immunisation program. Medical Journal of Australia, 189(5), 243-244. DOI Scopus5 WoS8 Europe PMC2 |
2008 |
Brotherton, J., Gold, M., Kemp, A., McIntyre, P., Burgess, M., & Campbell-Lloyd, S. (2008). Anaphylaxis following quadrivalent human papillomavirus vaccination. Canadian Medical Association Journal, 179(6), 525-533. DOI Scopus101 WoS88 Europe PMC52 |
2008 |
Palmer, D., Gold, M., & Makrides, M. (2008). Effect of maternal egg consumption on breast milk ovalbumin concentration. Clinical and Experimental Allergy, 38(7), 1186-1191. DOI Scopus59 WoS49 Europe PMC27 |
2008 |
Lawrence, G., Gold, M., Hill, R., Deeks, S., Glasswell, A., & McIntyre, P. (2008). Annual report: surveillance of adverse events following immunisation in Australia, 2007. Communicable Diseases Intelligence Quarterly Report, 32(4), 371-387. Scopus23 Europe PMC11 |
2008 |
Grüber, C., Warner, J., Hill, D., Bauchau, V., Warner, J. O., Naspitz, C. K., . . . Abeck, D. (2008). Early atopic disease and early childhood immunization - Is there a link?. Allergy: European Journal of Allergy and Clinical Immunology, 63(11), 1464-1472. DOI Scopus49 WoS36 Europe PMC22 |
2008 |
Grüber, C., Warner, J., Hill, D., Bauchau, V., Warner, J. O., Naspitz, C. K., . . . Abeck, D. (2008). Early atopic disease and early childhood immunization - Is there a link?. Allergy: European Journal of Allergy and Clinical Immunology, 63(11), 1464-1472. DOI Scopus49 WoS36 Europe PMC22 |
2008 |
Hill, D. J., Hosking, C. S., de Benedictis, F. M., Oranje, A. P., Diepgen, T. L., Bauchau, V., & EPAAC Study Group. (2008). Confirmation of the association between high levels of immunoglobulin E food sensitization and eczema in infancy: an international study. Clinical & Experimental Allergy, 38(1), 161-168. DOI Scopus188 WoS157 Europe PMC92 |
2008 |
Hill, D. J., Hosking, C. S., de Benedictis, F. M., Oranje, A. P., Diepgen, T. L., Bauchau, V., & EPAAC Study Group. (2008). Confirmation of the association between high levels of immunoglobulin E food sensitization and eczema in infancy: an international study. Clinical & Experimental Allergy, 38(1), 161-168. DOI Scopus188 WoS157 Europe PMC92 |
2007 |
Lawrence, G., Aratchige, P., Boyd, I., McIntyre, P., & Gold, M. (2007). Annual report on surveillance of adverse events following immunisation in Australia 2006. Communicable Disease Intelligence, 31(3), 269-282. Scopus13 Europe PMC4 |
2007 |
Ruggeberg, J., Gold, M., Bayas, J., Blum, M., Bonhoeffer, J., Friedlander, S., . . . Simpson, N. (2007). Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine, 25(31), 5675-5684. DOI Scopus316 Europe PMC213 |
2006 |
Gold, M. (2006). Prevention and Management of Anaphylaxis in Schools - The Challenge of Policy and Practice. Allergy and Clinical Immunology International, 18(1), 11-14. DOI Scopus2 |
2006 |
Peadon, E., Burgner, D., Nissen, M., Buttery, J., Zurynski, Y., Elliott, E., . . . Booy, R. (2006). Case for varicella surveillance in Australia. Journal of Paediatrics and Child Health, 42(11), 663-664. DOI Scopus7 WoS2 Europe PMC5 |
2006 |
Hofman, T., Cranswick, N., Kuna, P., Boznanski, A., Latos, T., Gold, M., . . . Szalai, Z. (2006). Tacrolimus ointment does not affect the immediate response to vaccination, the generation of immune memory, or humoral and cell-mediated immunity in children. Archives of Disease in Childhood, 91(11), 905-910. DOI Scopus32 WoS26 Europe PMC17 |
2006 |
Marshall, H., Gold, M., Gent, R., Quinn, P., Piotto, L., Clarke, M., & Roberton, D. (2006). Ultrasound examination of extensive limb swelling reactions after diphtheria-tetanus-acellular pertussis or reduced-antigen content diphtheria-tetanus-acellular pertussis immunization in preschool-aged children. Pediatrics, 118(4), 1501-1509. DOI Scopus21 WoS19 Europe PMC13 |
2006 |
Brown, S., Mullins, R., & Gold, M. (2006). Anaphylaxis: diagnosis and management. Medical Journal of Australia, 185(5), 283-289. DOI Scopus124 Europe PMC48 |
2006 |
Brown, S. G. A., Mullins, R. J., & Gold, M. S. (2006). Allergy - 2. Anaphylaxis: diagnosis and management. MEDICAL JOURNAL OF AUSTRALIA, 185(5), 283-289. DOI WoS103 |
2006 |
Brown, S. G. A., Mullins, R. J., & Gold, M. S. (2006). Erratum: "2. Anaphylaxis: Diagnosis and management" (Medical Journal of Australia (2006) vol. 185 ( 283-289)). Medical Journal of Australia, 185(7), 400. DOI Scopus2 |
2005 |
Gold, M. S., & Kemp, A. S. (2005). 6. Atopic disease in childhood. Medical Journal of Australia, 182(6), 298-304. DOI Scopus61 Europe PMC33 |
2005 |
Palmer, D., Gold, M., & Makrides, M. (2005). Effect of cooked and raw egg consumption on ovalbumin content of human milk: a randomized, double-blind, cross-over trial. Clinical and Experimental Allergy, 35(2), 173-178. DOI Scopus84 WoS71 Europe PMC46 |
2004 |
Morwood, K., Bourne, H., Philpot, R., Gold, M., Gillis, D., & Benson, E. (2004). Phenotypic variability: Clinical presentation between the 6th year and the 60th year in a family with X-linked agammaglobulinemia. Journal of Allergy and Clinical Immunology, 113(4), 783-785. DOI Scopus19 Europe PMC10 |
2004 |
Smith, W., Thompson, D., Kummerow, M., Quinn, P., & Gold, M. (2004). A2 milk is allergenic. Medical Journal of Australia, 181(10), 574. DOI |
2004 |
Palmer, D., Gold, M., & Makrides, M. (2004). Treatment and prevention of food allergies in breastfed infants: practice and evidence. Nutrition & Dietetics, 61(2), 76-81. |
2004 |
Roberton, D., Marshall, H., Dinan, L., Boros, C., & Gold, M. (2004). Developmental immunology and vaccines: immune responses to vaccines in premature infants. Expert Review of Vaccines, 3(4), 343-347. DOI Scopus7 Europe PMC3 |
2004 |
Bonhoeffer, J., Gold, M., Heijbel, H., Vermeer, P., Blumberg, D., Braun, M., . . . Nokleby, H. (2004). Hypotonic-Hyporesponsive Episode (HHE) as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation. Vaccine, 22(5-6), 563-568. DOI Scopus21 Europe PMC14 |
2004 |
Bonhoeffer, J., Menkes, J., Gold, M., de Souza-Brito, G., Fisher, M., Halsey, N., & Vermeer, P. (2004). Generalized convulsive seizure as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation. Vaccine, 22(5-6), 557-562. DOI Scopus81 Europe PMC45 |
2004 |
Baumgart, K., Brown, S., Gold, M., Kemp, A., Loblay, R., Loh, R., . . . Ziegler, J. (2004). ASCIA guidelines for prevention of food anaphylactic reactions in schools, preschools and child-care centres. Journal of Paediatrics and Child Health, 40(12), 669-671. DOI Scopus33 WoS34 Europe PMC12 |
2003 |
Gold, M. (2003). EpiPen epidemic or good clinical practice?. Journal of Paediatrics and Child Health, 39(5), 376-377. DOI Scopus14 WoS15 Europe PMC12 |
2003 |
Gold, M., Noonan, S., Osbourn, M., Precepa, S., & Kempe, A. (2003). Local reactions after the fourth-dose of acellular pertussis vaccine in South Australia. Medical Journal of Australia, 179(4), 191-194. DOI Scopus30 Europe PMC9 |
2003 |
Goldwater, P., Braunack-Mayer, A., Power, R., Henning, P., Gold, M., Donald, T., . . . Finlay, C. (2003). Childhood tetanus in Australia: ethical issues for a should-be-forgotten preventable disease. Medical Journal of Australia, 178(4), 175-177. DOI Scopus3 WoS3 Europe PMC1 |
2003 |
Gold, M. (2003). Vaccination strategy for children with previous vaccine-associated adverse reactions. Vaccines: Children and Practice, 6(1), 5-8. Scopus1 |
2003 |
Palmer, D. J., Gold, M. S., & Makrides, M. (2003). The effect of egg ingestion on ovalbumin concentration in human milk.. Asia Pacific Journal of Clinical Nutrition, 12(Suppl), S46. |
2002 |
Turnbull, F., McIntyre, P., Achat, H., Wang, H., Stapledon, R., Gold, M., & Burgess, M. (2002). National study of adverse reactions after vaccination with bacille Calmette-Guérin. Clinical Infectious Diseases, 34(4), 447-453. DOI Scopus88 WoS65 Europe PMC41 |
2002 |
Gold, M. (2002). Hypotonic-Hyporesponsive Episodes Following Pertussis Vaccination: A Cause for Concern?. Drug Safety, 25(2), 85-90. DOI Scopus17 Europe PMC7 |
2001 |
Boros, C., Hanlon, M., Gold, M., & Roberton, D. (2001). Storage at -3oC for 24 h alters the immunogenicity of pertussis vaccines. Vaccine, 19(25-26), 3537-3542. DOI Scopus32 WoS31 Europe PMC17 |
2000 |
Gold, M. (2000). The prevention, diagnosis and management of allergic disease in childhood. Current Paediatrics, 10(3), 137-144. DOI |
2000 |
Gold, M., Goodwin, H., Botham, S., Burgess, M., Nash, M., & Kempe, A. (2000). Re-vaccination of 421 children with a past history of an adverse vaccine reaction in a special immunisation service. Archives of Disease in Childhood, 83(2), 128-131. DOI Scopus66 Europe PMC29 |
2000 |
Boros, C., Kay, D., & Gold, M. (2000). Parent reported allergy and anaphylaxis in 4173 South Australian children. Journal of Paediatrics and Child Health, 36(1), 36-40. DOI Scopus81 WoS68 Europe PMC30 |
2000 |
Gold, M., & Sainsbury, R. (2000). First aid anaphylaxis management in children who were prescribed an epinephrine autoinjector device (EpiPen). Journal of Allergy and Clinical Immunology, 106(1), 171-176. DOI Scopus212 WoS183 Europe PMC103 |
2000 |
D'Souza, R. M., Campbell-Lloyd, S., Isaacs, D., Gold, M., Burgess, M., Turnbull, F., & O'Brien, E. (2000). Adverse events following immunisation associated with the 1998 Australian Measles Control Campaign.. Communicable diseases intelligence, 24(2), 27-33. Scopus39 Europe PMC19 |
1999 |
Gold, M., Kempe, A., & Osbourn, M. (1999). A comparison of serious adverse reactions to whole cell and acellular pertussis vaccines in South Australia [2]. Medical Journal of Australia, 171(6), 331-332. DOI Scopus15 Europe PMC8 |
1999 |
Gold, M., Martin, L., Nayda, C., & Kempe, A. (1999). Electronic temperature monitoring and feedback to correct adverse vaccine storage in general practice. Medical Journal of Australia, 171(2), 83-84. DOI Scopus20 Europe PMC10 |
1999 |
Goodwin, H., Nash, M., Gold, M., Heath, T., & Burgess, M. (1999). Vaccination of children following a previous hypotonic-hyporesponsive episode. Journal of Paediatrics and Child Health, 35(6), 549-552. DOI Scopus34 Europe PMC15 |
1998 |
Gold, M., Kemp, A., & Osbourne, M. (1998). (Letter) Counting the cost of disrupting the vaccine cold chain. Medical Journal of Australia, 168(9), 471-472. |
1998 |
Gold, M. S., Kemp, A. E., & Osbourne, M. (1998). Counting the cost of disrupting the vaccine cold chain [4]. Medical Journal of Australia, 168(9), 471-472. DOI Scopus4 Europe PMC2 |
1997 |
Wawryk, A., Mavromatis, C., & Gold, M. (1997). Electronic monitoring of the vaccine cold chain in a metropolitan area. British Medical Journal, 315(7107), 518. DOI Scopus23 Europe PMC10 |
1997 |
Hammond, P., Gold, M., Wigg, N., & Volkmer, R. (1997). Preschool hearing screening: Evaluation of a parental questionnaire. Journal of Paediatrics and Child Health, 33(6), 528-530. DOI Scopus12 Europe PMC9 |
1990 |
Gold, M. S., Hill, I. D., & Bowie, M. D. (1990). Primary peptic ulcer disease in childhood. South African Medical Journal, 77(4), 183-185. Scopus3 Europe PMC1 |